missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CHREBP Antibody [Janelia Fluor™ 635], Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals (Bio-Techne) NB400-135JF635
This item is not returnable.
View return policy
Description
CHREBP Polyclonal antibody specifically detects CHREBP in Human,Mouse,Rat samples. It is validated for ChIP assay,Immunohistochemistry,Immunoprecipitation,Western Blot,Immunohistochemistry (Paraffin),Immunoblot,Gel Super Shift Assays,SDS-Page,ChIP assay (ChIP),Gene Knock-Out,Immunocytochemistry/ Immunofluorescence
Specifications
| CHREBP | |
| Polyclonal | |
| 50mM Sodium Borate | |
| Rabbit | |
| Immunogen affinity purified | |
| RUO | |
| Primary | |
| Human, Mouse, Rat | |
| Purified |
| ChIP Assay, Immunohistochemistry, Immunoprecipitation, Western Blot, Immunohistochemistry (Paraffin), Immunoblot, Gel Supershift, SDS-Page, ChIP Assay, Gene Knock-Out, Immunocytochemistry/Immunofluorescence | |
| Janelia Fluor 635 | |
| BHLHD14, CHREBPcarbohydrate-responsive element-binding protein, Class D basic helix-loop-helix protein 14, MIOWS basic-helix-loop-helix leucine zipper protein, MLX interacting protein-like, MLX interactor, MLX-interacting protein-like, MONDOBWilliams-Beuren syndrome chromosomal region 14 protein, WBSCR14Williams-Beuren syndrome chromosome region 14 protein 1, Williams Beuren syndrome chromosome region 14, Williams-Beuren syndrome chromosome region 14 protein 2, WS-bHLHbHLHd14carbohydrate response element binding protein | |
| A C-terminal synthetic peptide made to the human CHREBP protein sequence (between residues 800-852). [UniProt# Q9NP71, Isoform 1/Alpha] | |
| 0.1 mL | |
| Cancer, Chromatin Research, DNA replication Transcription Translation and Splicing, Lipid and Metabolism, Transcription Factors and Regulators | |
| 51085 | |
| Store at 4°C in the dark. | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction